Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T22658 | ||||
Target Name | Interleukin-8 | ||||
Synonyms | Emoctakin; GCP-1; Granulocyte chemotacticprotein 1; IL-8; LYNAP; Lymphocyte-derived neutrophil-activating factor; MDNCF; MONAP; Monocyte derived neutrophil activating peptide; Monocyte-derived neutrophil chemotactic factor; NAF; NAP-1; Neutrophil-activating factor; Neutrophil-activating protein 1; Protein 3-10C; T-cell chemotactic factor; CXCL8 | ||||
Target Type | Clinical Trial | ||||
Gene Name | CXCL8 | ||||
Biochemical Class | Intercrine-alpha family | ||||
UniProt ID | IL8_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Melanoma | ||||
Example drug | ABX-IL8 | Phase 2 | [521511], [1572592] | ||
Tissue | Skin | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: 2.09 Z-score: 3.08 P-value: 9.05E-17 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.